Wobble Genomics secures £1.2m seed investment led by Eos Advisory to expand team and drive sales
The funding round was led by Eos Advisory alongside Old College Capital as part of a wider £2.2m seed financing.
Wobble Genomics is a University of Edinburgh spin-out that has developed a novel approach to RNA sequencing. The company focuses on detecting full-length RNA to support various biotechnology applications.
Genetic sequencing specialist Wobble Genomics has secured a £1.2m investment round led by Eos Advisory, with participation from Old College Capital. The funding will support team expansion, intellectual property strengthening, sales growth, and clinical outcome demonstrations.
The capital forms part of a wider £2.2m seed financing that also involves a deeptech venture capital firm and private backers. Wobble emerged as a spin-out from the University of Edinburgh's Roslin Institute in April 2021 under the leadership of CEO Richard Kuo.
From the founder
"There is a huge global market of scientists and clinicians who would buy our products as part of their sequencing work."
Richard Kuo
CEO at Wobble Genomics
Investor perspective
"Richard is already a globally respected researcher in RNA sequencing, and now has the ability to build a team to commercialise novel approaches that address the big issues and understanding of this exciting field of life science."
Andrew McNeill
Managing Partner, Eos Advisory
Use of funds
- 01Grow the team
- 02Continue product development
- 03Invest in sales and marketing
Investors
Categories
About the company
Wobble Genomics
Wobble Genomics develops a novel approach to RNA sequencing for biotechnology applications.